Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 351,047 | 137,184 | 207,537 | 79,449 | 82,673 |
| Marketable Securities | 610,154 | 412,397 | 379,713 | 335,907 | 396,717 |
| TOTAL | $970,866 | $559,409 | $604,785 | $430,031 | $494,377 |
| Non-Current Assets | |||||
| PPE Net | 42,265 | 43,622 | 45,452 | 46,732 | 47,481 |
| Investments And Advances | 20,341 | 7,229 | 9,684 | 39,886 | 23,534 |
| Other Non-Current Assets | 36,834 | 37,077 | 35,944 | 36,582 | 37,586 |
| TOTAL | $99,440 | $87,928 | $91,080 | $123,200 | $108,601 |
| Total Assets | $1,070,306 | $647,337 | $695,865 | $553,231 | $602,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,806 | 1,866 | 2,316 | 2,590 | 2,022 |
| Accrued Expenses | 4,689 | 4,179 | 5,349 | N/A | 15,467 |
| Other current liabilities | 93,410 | 48,089 | 35,849 | 42,754 | 29,196 |
| TOTAL | $105,413 | $58,464 | $47,635 | $45,344 | $46,685 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 82,343 | 86,706 | 102,919 | 112,997 | 118,096 |
| TOTAL | $82,343 | $86,706 | $102,919 | $112,997 | $118,096 |
| Total Liabilities | $187,756 | $145,170 | $150,554 | $158,341 | $164,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,919 | 105,983 | 105,628 | 105,423 | 96,031 |
| Common Shares | 1,524 | 1,385 | 1,382 | 1,288 | 1,286 |
| Retained earnings | -599,300 | -541,072 | -482,314 | -425,551 | -371,526 |
| Other shareholders' equity | 11 | 551 | 835 | 350 | 562 |
| TOTAL | $882,550 | $502,167 | $545,311 | $394,890 | $438,197 |
| Total Liabilities And Equity | $1,070,306 | $647,337 | $695,865 | $553,231 | $602,978 |